Smoking cessation electronic visit (e-visit) for Smoking, Cessation

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Smoking, Cessation
Smoking cessation e-visit - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether an electronic visit (e-visit) for smoking cessation is effective. Participants will be assigned at random to either receive the e-visit or not. The e-visit will be in the form of an online questionnaire about smoking history, motivation to quit, and preferences for quitting medications. If participants are randomized to the e-visit group, they may receive a prescription for a smoking cessation medication, but they are not required to take it. The study will last 24 weeks and consist of four time points where participants will answer questionnaires and provide breath samples.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

6 Primary · 0 Secondary · Reporting Duration: Month 6

Month 6
Cigarettes smoking
E-visit Acceptability
E-visit Adoption
Number of participants who utilized smoking cessation treatment
Quit attempts
Seven-day point prevalence abstinence

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Treatment as usual (TAU)
1 of 2
Smoking cessation electronic visit (e-visit)
1 of 2
Active Control
Experimental Treatment

672 Total Participants · 2 Treatment Groups

Primary Treatment: Smoking cessation electronic visit (e-visit) · No Placebo Group · N/A

Smoking cessation electronic visit (e-visit)
Behavioral
Experimental Group · 1 Intervention: Smoking cessation e-visit · Intervention Types: Behavioral
Treatment as usual (TAU)
Behavioral
ActiveComparator Group · 1 Intervention: Treatment As Usual · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Smoking cessation e-visit
2019
N/A
~60

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: month 6

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
12,989 Previous Clinical Trials
41,298,386 Total Patients Enrolled
83 Trials studying Smoking, Cessation
1,092,118 Patients Enrolled for Smoking, Cessation
Medical University of South CarolinaLead Sponsor
833 Previous Clinical Trials
5,372,552 Total Patients Enrolled
15 Trials studying Smoking, Cessation
7,447 Patients Enrolled for Smoking, Cessation

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are the owner of an iOS or Android smartphone to provide remote CO.
You have a valid mailing address.
You are fluent in English.\n

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 28th, 2021

Last Reviewed: October 30th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.